Patient Engagement Synapse
  • Join now
  • Login
    • Add Organization
    • Add Initiative
    • Add Event
    • Add Resource
  • Join now
  • Login
  • Home
  • People
  • Organizations
  • Initiatives
  • Events
  • Resources
  • Conditions
  • Countries
  • Trainings
  • Reports
  • Metrics Selector
COVID-19 hub

Coronavirus Resource Hub

  1. Home
  2. Blog
  3. Podcast: How can we future-proof medicines regulation in the post-COVID world?
Podcast: How can we future-proof medicines regulation in the post-COVID world?
By EFPIA 23 March 2021
medicine regulation covid 19

Nathalie Moll, Director General of EFPIA on “How can we future-proof medicines regulation in the post-COVID world?”.

Go to the article
Perspectives
prev Back to articles next

Synapse features

in relation to Covid-19
10 PEOPLE 82 ORGANIZATIONS 38 EVENTS 190 RESOURCES
Global resources
  • ECDC News and Publications
  • WHO (Regional Office for Europe) Latest updates
  • WHO Recommendation for International Travel
  • WHO Q&A
  • NHS Advice for Public
  • WHO Advice for Public
  • WHO Situation Map
  • WHO Press briefings
Industry resources
  • Pharma response to the pandemic
National government sites
  • United States
  • France
  • Germany
  • The Netherlands
  • Spain
  • United Kingdom
  • Switzerland
  • Belgium

Do you need help?

  • Contact us
  • Latest updates
  • Cookie privacy options

Useful links

  • About us
  • Features
  • Search tool
  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Geographical
  • Medical scope
  • Timeline
  • Patient matrix
  • Medicine lifecycle

Discover more

  • Synapse for Maternal Health
  • Synapse for Precision Medicine
  • Synapse for Medtech
  • Synapse for Digital Health
  • Ukrainian Health

Subscribe

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.

6.9.0@prod
© Copyright SYNAPSE 2022. All Rights Reserved Powered by The Synergist.
Twitter LinkedIn Youtube